Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001437749-17-017237

Options or other derivatives

  • Executive Chairman acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ARMEN GARO H Executive Chairman 2017-10-16 Grant or award · Non-Qualified Stock Options (Right to Buy) +250,000 250,000 D
Loading xslF345X03/rdgdoc.xml…